Comparison of the clinical efficacy of primary percutaneous coronary intervention with thrombolytic therapy for acute myocardial infarction

Hong-mei GUO,Biao XU,Jie SONG,Yu-lu LIANG,Rong-lin ZHANG,Lian WANG,Guang-fei SHI

DOI: https://doi.org/10.3969/j.issn.1003-9198.2005.05.007

2005-01-01

Abstract:Objective To compare the clinical efficacy of primary percutaneous coronary interventions(PCI) with that of thrombolytic therapy for acute ST segment elevated myocardial infarction (STEMI) patients. Methods Totally, 108 STEMI patients were enrolled, 66 patients underwent primary PCI (PCI group), and 42 patients were treated with thrombolytic drug: urokinase therapy (UK group). The recanalizing rate of IRA, mortality, left ventricular function and major cardiac events rate between the two groups of patients were compared. Results Clinical outcomes during hospitalization : In PCI group, the recanalizing rate of IRA was higher(P0.01),in-hospital mortality was lower(P0.05),indexes of left ventricular function were better. Major cardiac event rates during follow-up: The rates of accumulative cardiac mortality(P0.05)and revascularization(P0.01)were lower in PCI group. Conclusions Compared to the thrombolytic therapy, primary PCI could more rapidly and efficaciously restore the blood flow in IRA, reduce in hospital mortality of AMI, improve left ventricular systolic function, decrease revascularization possibility of IRA and mortality during follow-up.